Avemar has been recognised and studied worldwide since 1998. As in vitro, in vivo and clinical studies provided further evidence of its safety and effectiveness in the supplementation of oncological treatments, Avemar was registered as “dietary food for special medical purposes for cancer patients” in 2002. Since the discovery of Avemar pulvis, the active ingredient of Avemar, over 13 years of scientific study has been conducted to support its safety and effectiveness, including in vitro, in vivo and human clinical research. Most of the prestigious publications are also published at the PubMed database.
- Improved the overall survival, metastases-free survival and progression-free survival of certain cancer patients
- Improved the tolerance for surgeries, chemotherapy and radiotherapy
- Enhanced and not interfered with the anticancer effects of chemotherapies
- Decreased the severity of the immune suppressive effects of surgery, radiation and chemotherapy
- Enhanced the quality of life and physical condition of early and late stage cancer patients (less fatigue, less pain and increased appetite)
- Up regulated the Th1 (cellular) immune function, while inhibiting Th2 (humoral) immune function
- Stimulated cancer cell apoptosis (programmed cell death)
- Enhance the ability of NK cells to identify and kill cancerous and other target cells by down regulating the presentation of MHC-I molecules on infected cells
- Stimulated the production of TNF-alpha by macrophages
- Enhanced the tumour invasive potential of immune system cells by up regulating ICAM-A molecules in micro-vascular endothelial cells
- Modified the glucose metabolism of cancer cells by decreasing intracellular glucose uptake and shifting glucose away from DNA synthesis
Learn more about the benefits of Avemar at: https://research.avemar.com
The information on this website is provided for informational purposes only and is not meant to diagnose or treat any health problem or disease or be a substitute for advice provided by a doctor or other qualified health care professional. Patients should always consult with a doctor or other health care professionals for medical advice or information about a diagnosis and/or treatment. In the case of diagnosis or treatment of any disease, particularly tumour related diseases, a health care professional should always be consulted. Do not attempt to self-treat.